These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7085123)

  • 41. Allergen IgE-isotype-specific suppression by maternally derived monoclonal anti-IgG-idiotype.
    Tanasa RI; Trad A; Lange H; Grötzinger J; Lemke H
    Allergy; 2010 Jan; 65(1):16-23. PubMed ID: 19624555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.
    Mori A; Thomas P; Tagaya Y; Iijima H; Grey H; Ishizaka K
    Int Immunol; 1993 Aug; 5(8):833-42. PubMed ID: 7691164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A method to generate antigen-specific suppressor T cells in vitro from peripheral blood T cells of honey bee venom-sensitive, allergic patients.
    Carini C; Iwata M; Warner J; Ishizaka K
    J Immunol Methods; 1990 Mar; 127(2):221-33. PubMed ID: 2138201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping human T cell epitopes on phospholipase A2: the major bee-venom allergen.
    Dhillon M; Roberts C; Nunn T; Kuo M
    J Allergy Clin Immunol; 1992 Jul; 90(1):42-51. PubMed ID: 1378459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
    Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K
    J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant allergen-based IgE testing to distinguish bee and wasp allergy.
    Mittermann I; Zidarn M; Silar M; Markovic-Housley Z; Aberer W; Korosec P; Kosnik M; Valenta R
    J Allergy Clin Immunol; 2010 Jun; 125(6):1300-1307.e3. PubMed ID: 20466415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.
    Carballido JM; Carballido-Perrig N; Oberli-Schrämmli A; Heusser CH; Blaser K
    J Allergy Clin Immunol; 1994 Apr; 93(4):758-67. PubMed ID: 8163785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of IgG and IgE antibody levels to honey bee venom allergens with protection to sting challenge.
    Hoffman DR; Gillman SA; Cummins LH; Kozak PP; Oswald A
    Ann Allergy; 1981 Jan; 46(1):17-23. PubMed ID: 6257151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An immunoenzyme assay for quantitation of human IgG antibodies to honeybee venom phospholipase A2.
    Tracy RP; Alport EC; Yunginger JW; Homburger HA
    J Immunol Methods; 1980; 32(2):185-93. PubMed ID: 6987314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.
    Carballido JM; Carballido-Perrig N; Terres G; Heusser CH; Blaser K
    Eur J Immunol; 1992 Jun; 22(6):1357-63. PubMed ID: 1601030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy.
    Kämmerer R; Chvatchko Y; Kettner A; Dufour N; Corradin G; Spertini F
    J Allergy Clin Immunol; 1997 Jul; 100(1):96-103. PubMed ID: 9257793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the antibody response to bee venom phospholipase A2 induced by natural exposure in humans or by immunization in mice.
    Schneider T; Dudler T; Annand RR; Gelb MH; King TP; Suter M
    J Mol Recognit; 1997; 10(2):93-100. PubMed ID: 9376132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of the enzyme-linked immunosorbent assay for measurement of allergen-specific antibodies.
    Urbanek R; Kemeny DM; Samuel D
    J Immunol Methods; 1985 May; 79(1):123-31. PubMed ID: 2582056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allergens in Hymenoptera venom XIV: IgE binding activities of venom proteins from three species of vespids.
    Hoffman DR
    J Allergy Clin Immunol; 1985 May; 75(5):606-10. PubMed ID: 3989146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. To bee or not to be? T-cell responses to bee venom PLA2 in relation to anaphylaxis and immunotherapy.
    McHugh SM
    Clin Exp Allergy; 1997 Sep; 27(9):986-90. PubMed ID: 9678827
    [No Abstract]   [Full Text] [Related]  

  • 57. [Bee venom allergy (a model of an IgE-mediated immediate-type allergy)].
    Jarisch R
    Wien Klin Wochenschr Suppl; 1980; 122():3-27. PubMed ID: 7013279
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term falls in antibodies to dust mite and pollen allergens in patients with asthma or hay fever.
    Rawle FC; Burr ML; Platts-Mills TA
    Clin Allergy; 1983 Sep; 13(5):409-17. PubMed ID: 6627618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased specificity of diagnostic tests with recombinant major bee venom allergen phospholipase A2.
    Müller U; Fricker M; Wymann D; Blaser K; Crameri R
    Clin Exp Allergy; 1997 Aug; 27(8):915-20. PubMed ID: 9291289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgG4 antibodies in hay fever patients. Difference in IgG4 response to tree pollen and grass pollen allergens.
    Chernokhvostova EV; Kotova TS; German GP; Atovmian OI
    Int Arch Allergy Appl Immunol; 1990; 92(3):217-22. PubMed ID: 2276839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.